Europe Hospital at Home Market Growth & Future 2031
Europe Hospital at Home Market Size and Forecast (2021 - 2031), Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Component (Equipment and Devices and Software and Services), Service Type (Acute Care at Home, Chronic Disease Management at Home, Post Acute or Transitional Care, Palliative Care and Hospice Care, and Rehabilitation Services), Delivery Mode (Remote Monitoring and Telehealth, In-person Home Visits, and Hybrid Models), Patient Demographic ( Adult Patients and Pediatric Patients), Indication (Cardiovascular Conditions, Respiratory Diseases, Orthopedic and Post-Surgical Recovery, Infectious Diseases, Neurological Rehabilitation, and Others), End User (Hospitals and Health Systems, Home Health Agencies, Primary Care or Physician Groups, and Private HaH Providers), and Geography
- Report Date : Jan 2026
- Report Code : TIPRE00042181
- Category : Life Sciences
- Status : Published
- Available Report Formats :
- No. of Pages : 198
The Europe hospital at home market size is projected to reach US$ 13.57 billion by 2031 from US$ 8.44 billion in 2024. The market is expected to register a CAGR of 7.1% from 2025 to 2031.
Europe Hospital at Home Market AnalysisThe rapidly aging population and rising prevalence of chronic diseases, constraints on hospital capacity, and shift toward ambulatory and community-based care, advancements in digital health technologies accelerated by the COVID-19 pandemic, are key factors driving market growth. Additionally, leveraging EU funding and recovery programs for HaH expansion, integration of digital health and AI technologies, and enhancing chronic disease management and access in rural areas are expected to create ample opportunities for the market in the coming years.
Europe Hospital at Home Market OverviewComprising virtual wards and acute care delivery at patients' homes is a significant trend for the future of the healthcare system. This model combines remote monitoring, multidisciplinary teams, nursing visits, and digital technologies to deliver hospital-level interventions safely at home, thus facilitating admission avoidance and early discharge.
Currently, the UK, through the NHS virtual wards, is leading the way in adoption for frailty, respiratory infections, and acute conditions. The focus is on technology, enabling care to ease bed pressures. In France, hospitalization domicile (HAD) is mainly for intricately handled cases such as infusion and palliative care through specialized structures. Countries such as Germany, Sweden, and the Netherlands are increasingly employing digital, physical, and telehealth-supported programs to tackle hospital overcrowding.
Private startups such as Doccla, Sciensus, Cera, Air Liquide Healthcare, and Philips are leading the way in the remote ecosystems innovation. The fragmented scene that merges public systems with private enablers to facilitate equity, staff training, and standardized implementation across regions is a blend of the two sectors.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Europe Hospital at Home Market: Strategic Insights
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Europe Hospital at Home Market Drivers and OpportunitiesCustomize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Europe Hospital at Home Market: Strategic Insights
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Market Drivers:
- Rapidly Aging Population and Rising Prevalence of Chronic Diseases: The multimorbidity of the elderly and Europe's aging population (21.6% over 65 in 2024, projected to 32.5% by 2100) are the main reasons for the HaH expansion, which helps to decrease the risk of hospitalizations, such as infections, and provides independent geriatric care.
- Constraints on Hospital Capacity and Shift Toward Ambulatory and Community-Based Care: The number of hospital beds in the EU has decreased by 8% from 2012 to 2022, which has caused the hospitals to transfer the patients to community care; HaH, by enabling acute care at home, thus liberating hospital beds, is a solution to overcrowding while keeping the quality of care high in countries with a low number of beds such as the UK and Sweden.
- Advancements in Digital Health Technologies Accelerated by the COVID-19 Pandemic: Telehealth adoption in Europe surged due to the COVID-19 pandemic. The use of remote monitoring, wearables, and AI is a method of lowering hospital readmission rates and a virtual ward solution in the UK, Norway, Sweden, and France's HAD system.
Market Opportunities:
- Leveraging EU Funding and Recovery Programs for HaH Expansion: EU4Health and other 2025 programs provide grants for digital health and health system resilience, by which HaH can be expanded with funding for infrastructure, training, and tools. This expansion can lead to a potential reduction in hospital admissions by 20, 30% in France and the UK.
- Integration of Advanced Digital Health and AI Technologies: Europe's strategy for digital health through EHDS, AI innovations, and telehealth adoption is to make HaH more efficient with remote monitoring and predictive analytics, thus chronic management is improved, readmissions are reduced by 15- 25%, and the workforce shortage problem is alleviated.
- Enhancing Chronic Disease Management and Access in Rural Areas: Projects in Poland, Italy, Ireland, and Greece implement home-based and telecare models to treat chronic diseases in rural areas, which in turn increases access, decreases hospital visits, and facilitates the fairness of the community through the integration of HaH services.
The Europe hospital at home market is divided into different segments to give a clearer view of how it works, its growth potential, and the latest trends. Below is the standard segmentation approach used in industry reports:
By Component:
- Equipment and Devices: Equipment and devices support the transformation of traditional hospital wards into the hospital at home setups by keeping the patients under remote medical surveillance through the use of wearable devices, vital signs monitors, infusion pumps, as well as oxygen concentrators of leading brands such as Philips and Medtronic.
- Software and Services: The demand for software and services is driven by digital platforms, telemedicine, analytics, and managed care from companies such as Doccla and Current Health.
By Service Type:
- Acute Care at Home
- Chronic Disease Management at Home
- Post Acute/ Transitional Care
- Palliative Care and Hospice Care
- Rehabilitation Services
By Delivery Mode:
- Remote Monitoring and Telehealth
- In-person Home Visits
- Hybrid Models
Patient Demographic:
- Adult Patients
- Pediatric Patients
Indication:
- Cardiovascular Conditions
- Respiratory Diseases
- Orthopedic and Post-Surgical Recovery
- Infectious Diseases
- Neurological Rehabilitation
- Others
Care Provider:
- Hospitals and Health Systems
- Home Health Agencies
- Primary Care/Physician Groups
- Private HaH Providers
By Geography:
- Europe
Market Report Scope
Europe Hospital at Home Market Share Analysis by GeographyEurope present opportunities for hospital at home providers.
The Europe hospital at home market grows differently in each nation due to the increasing prevalence of chronic disorders, surging government initiatives, and rising inclination toward home care. Below is a summary of market share and trends by region:
1. Europe
- Market Share: Germany holds a significant portion of the Europe market
- Key Drivers: Rapidly aging population, rising prevalence of chronic diseases, and hospital capacity constraints and cost pressures
- Trends: Digital Integration and AI and Expansion of Virtual Wards
High Market Density and Competition
Competition is intense due to the presence of established players such as Doccla, Air Liquide, Cera Care, and LNA Santé. Regional and niche players add to the competitive landscape across regions.
This high level of competition urges companies to stand out by offering:
- Advanced Products
- Value-added services such as customization and sustainable solutions
- Competitive pricing models
- Regulatory compliance
Opportunities and Strategic Moves
- Governments in Germany, France, the UK, and Spain are reducing the hospital burden by responding to the rising demand for cost-effective care by promoting HaH (Hospital at Home) programs for chronic conditions such as diabetes and post-surgical recovery.
- The scope of these programs is extended by digital tools, including telemedicine, remote patient monitoring (RPM), and wearables, which are backed by the high level of internet access and EU initiatives such as EU4Health and Horizon Europe.
- Philips joined with smartQare for the creation of integrated monitoring platforms across Europe, and Owlet Inc. It introduced EU-certified baby monitors in Germany, France, and the UK.
- Health systems commit themselves to the integration of telehealth and the training of the workforce to scale HaH, with the NHS being at the forefront of palliative care models. There is a focus on product launches, partnerships, and investments in AI, driven tools as a means to manage chronic diseases and support aging in place, which leads to the creation of ecosystems among hospitals, payers, and tech firms.
- Koninklijke Philips N.V.
- Fresenius SE & Co. KGaA
- Huma
- Medtronic
- Clariane (formerly Korian)
- emeis (formerly Orpea)
- Linde Healthcare
- HaD France
- Colisée
- DomusVi
- Kenbi
- Qida
- Inizio Engage
- Mediq
- Siemens Healthineers
- Roche Diagnostics
- Baxter International
- Alloheim (via homecare links)
- Attendo
- Barchester Healthcare
- HC-One
- Birdie
- Heim Health
- In September 2025, Air Liquide was awarded a large contract in Spain to care for patients living with respiratory conditions at home. The Community of Madrid, Spain, has selected Air Liquide to support at home 70,000 patients living with respiratory conditions, such as chronic obstructive pulmonary disease (COPD) and sleep apnea. The healthcare services provided at home enable chronic patients to meet their needs and maintain their autonomy and quality of life.
- In September 2024, Doccla built a virtual bed tech to help doctors remotely manage patients who have either been discharged early or, in some cases, never go to the hospital at all. After gaining traction in the UK and Ireland, it has now raised US$ 46 million (Euro 35 million) to expand in Europe.
The " Europe Hospital at Home Market Size and Forecast (2021–2031)" report provides a detailed analysis of the market covering below areas:
- Hospital at Home market size and forecast at global, regional, and country levels for all the key segments covered under the scope
- Hospital at Home market trends, as well as dynamics such as drivers, restraints, and key opportunities
- Detailed PEST and SWOT analysis
- Hospital at Home market analysis covering key trends, global and regional framework, major players, regulations, and recent market developments
- Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments for the market
- Detailed company profiles
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
Germany dominated the market in 2024.
Rapidly aging population and rising prevalence of chronic diseases, constraints on hospital capacity and shift toward ambulatory and community-based care, advancements in digital health technologies accelerated by the COVID-19 pandemic are among the major factors propelling market growth.
The Europe hospital at home market is estimated to register a CAGR of 7.1% during the forecast period.
The Europe hospital at home market is estimated to reach a value of US$ 13.57 billion by 2031.
B Braun SE, Huma Therapeutics Limited, Doccla, LNA-Santé (Hospital Care at Home), Inhealthcare, Spirit Health Group Ltd, Air Liquide (Air Liquide Healthcare), RIBERA SALUD, Capio Sverige AB (Ramsay Santé), and Medtronic Plc are among the key players operating in the Europe hospital at home market.
1. Executive Summary
1.1 Analyst Market Outlook
1.2 Market Attractiveness
2. Europe Hospital-at-Home Market Landscape
2.1 Overview
2.2 Value Chain Analysis
2.2.1 Raw Material Suppliers / Components
2.2.2 Manufacturers/ Process / Technology
2.2.3 Distribution Landscape
2.2.4 End User
2.2.5 Level of Integration
2.3 Supply Chain Analysis
2.3.1 List of Manufacturers/Suppliers
2.3.2 List of Potential Customers
2.4 Porter`s Five Force Analysis
2.4.1 Bargaining Power of Suppliers:
2.4.2 Bargaining Power of Buyers:
2.4.3 Threat of New Entrants:
2.4.4 Threat of Substitutes:
2.4.5 Competitive Rivalry:
2.5 PEST Analysis
2.6 Import–Export Analysis for Key Countries (As per the nearest HS Code)
2.6.1 Import and Export Analysis by HS Code 940290 (Operating tables, examination tables, and other medical, dental, surgical or veterinary furniture), 2024
2.6.2 Import and Export Analysis by HS Code 901831 (Syringes, with or without needles, used in medical, surgical, dental or veterinary sciences), 2024
2.6.3 Import and Export Analysis by HS Code 901920 (Ozone therapy, oxygen therapy, aerosol therapy, artificial respiration or other therapeutic respiration apparatus, incl. parts and accessories), 2024
2.6.4 Import and Export Analysis by HS Code 871310 (Carriages for disabled persons, not mechanically propelled), 2024
2.7 Patent Analysis by Products
2.7.1 Patent Analysis by Blood Glucose Monitors
2.7.2 Patent Analysis by Vital Sign Monitors
2.7.3 Patent Analysis by Wheelchairs
2.7.4 Patent Analysis by Medical Beds
2.7.5 Patent Analysis by Home Respirators
2.8 Impact of Artificial Intelligence (AI)
2.9 Product or Technology Roadmap
2.10 Sustainability and ESG Trends
2.10.1 Environmental Trends
2.10.2 Social Trends
2.10.3 Governance Trends
2.11 Regulatory Framework
3. Competitive Landscape
3.1 Company Benchmarking by Key Players
3.1.1 Company Market Share (%) Analysis, 2024
3.2 Market Concentration
4. Europe Hospital-at-Home Market – Key Industry Dynamics
4.1 Market Drivers
4.1.1 Rapidly Aging Population and Rising Prevalence of Chronic Diseases
4.1.2 Constraints on Hospital Capacity and Shift Toward Ambulatory and Community-Based Care
4.1.3 Advancements in Digital Health Technologies Accelerated by the COVID-19 Pandemic
4.2 Market Restraints
4.2.1 Severe Shortages in the Healthcare Workforce
4.2.2 Persistent Digital Divide and Low Digital Literacy Among Older Adults
4.2.3 Fragmented Regulatory Frameworks and Inconsistent Reimbursement Policies
4.3 Market Opportunities
4.3.1 Leveraging EU Funding and Recovery Programs for HaH Expansion
4.3.2 Integration of Advanced Digital Health and AI Technologies
4.3.3 Enhancing Chronic Disease Management and Access in Rural Areas
4.4 Future Trends
4.4.1 Widespread Adoption of Device-Based Remote Monitoring in Hospital-at-Home Models
4.4.2 Hospital at Home as a Key Driver for Sustainable and Green Healthcare
4.4.3 Integration of Artificial Intelligence for Predictive and Personalized Hospital-at-Home Care
4.5 Impact of Drivers and Restraints
5. Europe Hospital-at-Home Market – Region Market Analysis
5.1 Europe Hospital-at-Home Market Overview
5.2 Europe Hospital-at-Home Market Revenue (US$ Million), 2021–2031
5.3 Europe Hospital-at-Home Market Forecast and Analysis
6. Europe Hospital-at-Home Market Revenue Analysis –Component
6.1 Europe Hospital-at-Home Market Forecasts and Analysis by Component
6.1.1 Equipment and Devices
6.1.1.1 Overview
6.1.1.2 Equipment and Devices: Europe Hospital-at-Home Market – Revenue, 2021–2031 (US$ Million)
6.1.2 Software and Services
6.1.2.1 Overview
6.1.2.2 Software and Services: Europe Hospital-at-Home Market – Revenue, 2021–2031 (US$ Million)
7. Europe Hospital-at-Home Market Revenue Analysis –Service Type
7.1 Europe Hospital-at-Home Market Forecasts and Analysis by Service Type
7.1.1 Acute Care at Home
7.1.1.1 Overview
7.1.1.2 Acute Care at Home: Europe Hospital-at-Home Market – Revenue, 2021–2031 (US$ Million)
7.1.2 Chronic Disease Management at Home
7.1.2.1 Overview
7.1.2.2 Chronic Disease Management at Home: Europe Hospital-at-Home Market – Revenue, 2021–2031 (US$ Million)
7.1.3 Post Acute or Transitional Care
7.1.3.1 Overview
7.1.3.2 Post Acute or Transitional Care: Europe Hospital-at-Home Market – Revenue, 2021–2031 (US$ Million)
7.1.4 Palliative Care and Hospice Care
7.1.4.1 Overview
7.1.4.2 Palliative Care and Hospice Care: Europe Hospital-at-Home Market – Revenue, 2021–2031 (US$ Million)
7.1.5 Rehabilitation Services
7.1.5.1 Overview
7.1.5.2 Rehabilitation Services: Europe Hospital-at-Home Market – Revenue, 2021–2031 (US$ Million)
8. Europe Hospital-at-Home Market Revenue Analysis –Delivery Mode
8.1 Europe Hospital-at-Home Market Forecasts and Analysis by Delivery Mode
8.1.1 Remote Monitoring and Telehealth
8.1.1.1 Overview
8.1.1.2 Remote Monitoring and Telehealth: Europe Hospital-at-Home Market – Revenue, 2021–2031 (US$ Million)
8.1.2 In-person Home Visits
8.1.2.1 Overview
8.1.2.2 In-person Home Visits: Europe Hospital-at-Home Market – Revenue, 2021–2031 (US$ Million)
8.1.3 Hybrid Models
8.1.3.1 Overview
8.1.3.2 Hybrid Models: Europe Hospital-at-Home Market – Revenue, 2021–2031 (US$ Million)
9. Europe Hospital-at-Home Market Revenue Analysis –Patient Demographic
9.1 Europe Hospital-at-Home Market Forecasts and Analysis by Patient Demographic
9.1.1 Adult Patients
9.1.1.1 Overview
9.1.1.2 Adult Patients: Europe Hospital-at-Home Market – Revenue, 2021–2031 (US$ Million)
9.1.2 Pediatric Patients
9.1.2.1 Overview
9.1.2.2 Pediatric Patients: Europe Hospital-at-Home Market – Revenue, 2021–2031 (US$ Million)
10. Europe Hospital-at-Home Market Revenue Analysis –Indication
10.1 Europe Hospital-at-Home Market Forecasts and Analysis by Indication
10.1.1 Cardiovascular Conditions
10.1.1.1 Overview
10.1.1.2 Cardiovascular Conditions: Europe Hospital-at-Home Market – Revenue, 2021–2031 (US$ Million)
10.1.2 Respiratory Diseases
10.1.2.1 Overview
10.1.2.2 Respiratory Diseases: Europe Hospital-at-Home Market – Revenue, 2021–2031 (US$ Million)
10.1.3 Orthopedic and Post-Surgical Recovery
10.1.3.1 Overview
10.1.3.2 Orthopedic and Post-Surgical Recovery: Europe Hospital-at-Home Market – Revenue, 2021–2031 (US$ Million)
10.1.4 Infectious Diseases
10.1.4.1 Overview
10.1.4.2 Infectious Diseases: Europe Hospital-at-Home Market – Revenue, 2021–2031 (US$ Million)
10.1.5 Neurological Rehabilitation
10.1.5.1 Overview
10.1.5.2 Neurological Rehabilitation: Europe Hospital-at-Home Market – Revenue, 2021–2031 (US$ Million)
10.1.6 Others
10.1.6.1 Overview
10.1.6.2 Others: Europe Hospital-at-Home Market – Revenue, 2021–2031 (US$ Million)
11. Europe Hospital-at-Home Market Revenue Analysis –End User
11.1 Europe Hospital-at-Home Market Forecasts and Analysis by End User
11.1.1 Hospitals and Health Systems
11.1.1.1 Overview
11.1.1.2 Hospitals and Health Systems: Europe Hospital-at-Home Market – Revenue, 2021–2031 (US$ Million)
11.1.2 Home Health Agencies
11.1.2.1 Overview
11.1.2.2 Home Health Agencies: Europe Hospital-at-Home Market – Revenue, 2021–2031 (US$ Million)
11.1.3 Primary Care or Physician Groups
11.1.3.1 Overview
11.1.3.2 Primary Care or Physician Groups: Europe Hospital-at-Home Market – Revenue, 2021–2031 (US$ Million)
11.1.4 Private HaH Providers
11.1.4.1 Overview
11.1.4.2 Private HaH Providers: Europe Hospital-at-Home Market – Revenue, 2021–2031 (US$ Million)
12. Europe Hospital-at-Home Market – Country Analysis
12.1 Europe Hospital-at-Home Market Breakdown by Countries
12.1.1 Germany Market
12.1.1.1 Germany: Europe Hospital-at-Home Market Revenue and Forecasts, 2021–2031 (US$ Million)
12.1.1.2 Germany: Europe Hospital-at-Home Market– By Segmentation
12.1.1.2.1 Component
12.1.1.2.2 Service Type
12.1.1.2.3 Delivery Mode
12.1.1.2.4 Patient Demographic
12.1.1.2.5 Indication
12.1.1.2.6 End User
12.1.2 United Kingdom Market
12.1.2.1 United Kingdom: Europe Hospital-at-Home Market Revenue and Forecasts, 2021–2031 (US$ Million)
12.1.2.2 United Kingdom: Europe Hospital-at-Home Market– By Segmentation
12.1.2.2.1 Component
12.1.2.2.2 Service Type
12.1.2.2.3 Delivery Mode
12.1.2.2.4 Patient Demographic
12.1.2.2.5 Indication
12.1.2.2.6 End User
12.1.3 France Market
12.1.3.1 France: Europe Hospital-at-Home Market Revenue and Forecasts, 2021–2031 (US$ Million)
12.1.3.2 France: Europe Hospital-at-Home Market– By Segmentation
12.1.3.2.1 Component
12.1.3.2.2 Service Type
12.1.3.2.3 Delivery Mode
12.1.3.2.4 Patient Demographic
12.1.3.2.5 Indication
12.1.3.2.6 End User
12.1.4 Italy Market
12.1.4.1 Italy: Europe Hospital-at-Home Market Revenue and Forecasts, 2021–2031 (US$ Million)
12.1.4.2 Italy: Europe Hospital-at-Home Market– By Segmentation
12.1.4.2.1 Component
12.1.4.2.2 Service Type
12.1.4.2.3 Delivery Mode
12.1.4.2.4 Patient Demographic
12.1.4.2.5 Indication
12.1.4.2.6 End User
12.1.5 Spain Market
12.1.5.1 Spain: Europe Hospital-at-Home Market Revenue and Forecasts, 2021–2031 (US$ Million)
12.1.5.2 Spain: Europe Hospital-at-Home Market– By Segmentation
12.1.5.2.1 Component
12.1.5.2.2 Service Type
12.1.5.2.3 Delivery Mode
12.1.5.2.4 Patient Demographic
12.1.5.2.5 Indication
12.1.5.2.6 End User
12.1.6 Netherlands Market
12.1.6.1 Netherlands: Europe Hospital-at-Home Market Revenue and Forecasts, 2021–2031 (US$ Million)
12.1.6.2 Netherlands: Europe Hospital-at-Home Market– By Segmentation
12.1.6.2.1 Component
12.1.6.2.2 Service Type
12.1.6.2.3 Delivery Mode
12.1.6.2.4 Patient Demographic
12.1.6.2.5 Indication
12.1.6.2.6 End User
12.1.7 Switzerland Market
12.1.7.1 Switzerland: Europe Hospital-at-Home Market Revenue and Forecasts, 2021–2031 (US$ Million)
12.1.7.2 Switzerland: Europe Hospital-at-Home Market– By Segmentation
12.1.7.2.1 Component
12.1.7.2.2 Service Type
12.1.7.2.3 Delivery Mode
12.1.7.2.4 Patient Demographic
12.1.7.2.5 Indication
12.1.7.2.6 End User
12.1.8 Belgium Market
12.1.8.1 Belgium: Europe Hospital-at-Home Market Revenue and Forecasts, 2021–2031 (US$ Million)
12.1.8.2 Belgium: Europe Hospital-at-Home Market– By Segmentation
12.1.8.2.1 Component
12.1.8.2.2 Service Type
12.1.8.2.3 Delivery Mode
12.1.8.2.4 Patient Demographic
12.1.8.2.5 Indication
12.1.8.2.6 End User
12.1.9 Rest of Europe Market
12.1.9.1 Rest of Europe: Europe Hospital-at-Home Market Revenue and Forecasts, 2021–2031 (US$ Million)
12.1.9.2 Rest of Europe: Europe Hospital-at-Home Market– By Segmentation
12.1.9.2.1 Component
12.1.9.2.2 Service Type
12.1.9.2.3 Delivery Mode
12.1.9.2.4 Patient Demographic
12.1.9.2.5 Indication
12.1.9.2.6 End User
13. Europe Hospital-at-Home Market Industry Landscape
14. Europe Hospital-at-Home Market – Key Company Profiles
14.1 B Braun SE
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 Huma Therapeutics Limited
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 Doccla
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 LNA-Santé
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 Inhealthcare
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 Spirit Health Group Ltd
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 Air Liquide
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments
14.8 RIBERA SALUD
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments
14.9 Capio Sverige AB
14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments
14.10 Medtronic Plc
14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments
15. Appendix
15.1 Glossary
15.2 Research Methodology and Approach
15.2.1 Secondary Research
15.2.2 Primary Research
15.2.3 Market Estimation Approach
15.2.3.1 Supply Side Analysis
15.2.3.2 Demand Side Analysis
15.2.4 Research Assumptions and Limitations
15.2.5 Currency Conversion
15.3 About The Insight Partners
15.4 Market Intelligence Cloud
List of TablesTable 1. Europe Hospital-at-Home Market Segmentation
Table 2. Import and Export Analysis by HS Code 940290 (Operating tables, examination tables, and other medical, dental, surgical or veterinary furniture), 2024
Table 3. Import and Export Analysis by HS Code 901831 (Syringes, with or without needles, used in medical, surgical, dental or veterinary sciences), 2024
Table 4. Import and Export Analysis by HS Code 901920 (Ozone therapy, oxygen therapy, aerosol therapy, artificial respiration or other therapeutic respiration apparatus, incl. parts and accessories), 2024
Table 5. Import and Export Analysis by HS Code 871310 (Carriages for disabled persons, not mechanically propelled), 2024
Table 6. Patent Analysis by Blood Glucose Monitors
Table 7. Patent Analysis by Vital Sign Monitors
Table 8. Patent Analysis by Wheelchairs
Table 9. Patent Analysis by Medical Beds
Table 10. Patent Analysis by Home Respirators
Table 11. List of Regulatory Bodies and Organizations
Table 12. Company Market Share (%) Analysis, 2024
Table 13. Europe Hospital-at-Home Market – Revenue, 2021–2024(US$ Million)
Table 14. Europe Hospital-at-Home Market – Revenue Forecast, 2025–2031(US$ Million)
Table 15. Germany: Europe Hospital-at-Home Market – Revenue, 2021–2024 (US$ Million) – by Component
Table 16. Germany: Europe Hospital-at-Home Market – Revenue Forecast, 2025–2031 (US$ Million) – by Component
Table 17. Germany: Europe Hospital-at-Home Market – Revenue, 2021–2024 (US$ Million) – by Service Type
Table 18. Germany: Europe Hospital-at-Home Market – Revenue Forecast, 2025–2031 (US$ Million) – by Service Type
Table 19. Germany: Europe Hospital-at-Home Market – Revenue, 2021–2024 (US$ Million) – by Delivery Mode
Table 20. Germany: Europe Hospital-at-Home Market – Revenue Forecast, 2025–2031 (US$ Million) – by Delivery Mode
Table 21. Germany: Europe Hospital-at-Home Market – Revenue, 2021–2024 (US$ Million) – by Patient Demographic
Table 22. Germany: Europe Hospital-at-Home Market – Revenue Forecast, 2025–2031 (US$ Million) – by Patient Demographic
Table 23. Germany: Europe Hospital-at-Home Market – Revenue, 2021–2024 (US$ Million) – by Indication
Table 24. Germany: Europe Hospital-at-Home Market – Revenue Forecast, 2025–2031 (US$ Million) – by Indication
Table 25. Germany: Europe Hospital-at-Home Market – Revenue, 2021–2024 (US$ Million) – by End User
Table 26. Germany: Europe Hospital-at-Home Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User
Table 27. United Kingdom: Europe Hospital-at-Home Market – Revenue, 2021–2024 (US$ Million) – by Component
Table 28. United Kingdom: Europe Hospital-at-Home Market – Revenue Forecast, 2025–2031 (US$ Million) – by Component
Table 29. United Kingdom: Europe Hospital-at-Home Market – Revenue, 2021–2024 (US$ Million) – by Service Type
Table 30. United Kingdom: Europe Hospital-at-Home Market – Revenue Forecast, 2025–2031 (US$ Million) – by Service Type
Table 31. United Kingdom: Europe Hospital-at-Home Market – Revenue, 2021–2024 (US$ Million) – by Delivery Mode
Table 32. United Kingdom: Europe Hospital-at-Home Market – Revenue Forecast, 2025–2031 (US$ Million) – by Delivery Mode
Table 33. United Kingdom: Europe Hospital-at-Home Market – Revenue, 2021–2024 (US$ Million) – by Patient Demographic
Table 34. United Kingdom: Europe Hospital-at-Home Market – Revenue Forecast, 2025–2031 (US$ Million) – by Patient Demographic
Table 35. United Kingdom: Europe Hospital-at-Home Market – Revenue, 2021–2024 (US$ Million) – by Indication
Table 36. United Kingdom: Europe Hospital-at-Home Market – Revenue Forecast, 2025–2031 (US$ Million) – by Indication
Table 37. United Kingdom: Europe Hospital-at-Home Market – Revenue, 2021–2024 (US$ Million) – by End User
Table 38. United Kingdom: Europe Hospital-at-Home Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User
Table 39. France: Europe Hospital-at-Home Market – Revenue, 2021–2024 (US$ Million) – by Component
Table 40. France: Europe Hospital-at-Home Market – Revenue Forecast, 2025–2031 (US$ Million) – by Component
Table 41. France: Europe Hospital-at-Home Market – Revenue, 2021–2024 (US$ Million) – by Service Type
Table 42. France: Europe Hospital-at-Home Market – Revenue Forecast, 2025–2031 (US$ Million) – by Service Type
Table 43. France: Europe Hospital-at-Home Market – Revenue, 2021–2024 (US$ Million) – by Delivery Mode
Table 44. France: Europe Hospital-at-Home Market – Revenue Forecast, 2025–2031 (US$ Million) – by Delivery Mode
Table 45. France: Europe Hospital-at-Home Market – Revenue, 2021–2024 (US$ Million) – by Patient Demographic
Table 46. France: Europe Hospital-at-Home Market – Revenue Forecast, 2025–2031 (US$ Million) – by Patient Demographic
Table 47. France: Europe Hospital-at-Home Market – Revenue, 2021–2024 (US$ Million) – by Indication
Table 48. France: Europe Hospital-at-Home Market – Revenue Forecast, 2025–2031 (US$ Million) – by Indication
Table 49. France: Europe Hospital-at-Home Market – Revenue, 2021–2024 (US$ Million) – by End User
Table 50. France: Europe Hospital-at-Home Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User
Table 51. Italy: Europe Hospital-at-Home Market – Revenue, 2021–2024 (US$ Million) – by Component
Table 52. Italy: Europe Hospital-at-Home Market – Revenue Forecast, 2025–2031 (US$ Million) – by Component
Table 53. Italy: Europe Hospital-at-Home Market – Revenue, 2021–2024 (US$ Million) – by Service Type
Table 54. Italy: Europe Hospital-at-Home Market – Revenue Forecast, 2025–2031 (US$ Million) – by Service Type
Table 55. Italy: Europe Hospital-at-Home Market – Revenue, 2021–2024 (US$ Million) – by Delivery Mode
Table 56. Italy: Europe Hospital-at-Home Market – Revenue Forecast, 2025–2031 (US$ Million) – by Delivery Mode
Table 57. Italy: Europe Hospital-at-Home Market – Revenue, 2021–2024 (US$ Million) – by Patient Demographic
Table 58. Italy: Europe Hospital-at-Home Market – Revenue Forecast, 2025–2031 (US$ Million) – by Patient Demographic
Table 59. Italy: Europe Hospital-at-Home Market – Revenue, 2021–2024 (US$ Million) – by Indication
Table 60. Italy: Europe Hospital-at-Home Market – Revenue Forecast, 2025–2031 (US$ Million) – by Indication
Table 61. Italy: Europe Hospital-at-Home Market – Revenue, 2021–2024 (US$ Million) – by End User
Table 62. Italy: Europe Hospital-at-Home Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User
Table 63. Spain: Europe Hospital-at-Home Market – Revenue, 2021–2024 (US$ Million) – by Component
Table 64. Spain: Europe Hospital-at-Home Market – Revenue Forecast, 2025–2031 (US$ Million) – by Component
Table 65. Spain: Europe Hospital-at-Home Market – Revenue, 2021–2024 (US$ Million) – by Service Type
Table 66. Spain: Europe Hospital-at-Home Market – Revenue Forecast, 2025–2031 (US$ Million) – by Service Type
Table 67. Spain: Europe Hospital-at-Home Market – Revenue, 2021–2024 (US$ Million) – by Delivery Mode
Table 68. Spain: Europe Hospital-at-Home Market – Revenue Forecast, 2025–2031 (US$ Million) – by Delivery Mode
Table 69. Spain: Europe Hospital-at-Home Market – Revenue, 2021–2024 (US$ Million) – by Patient Demographic
Table 70. Spain: Europe Hospital-at-Home Market – Revenue Forecast, 2025–2031 (US$ Million) – by Patient Demographic
Table 71. Spain: Europe Hospital-at-Home Market – Revenue, 2021–2024 (US$ Million) – by Indication
Table 72. Spain: Europe Hospital-at-Home Market – Revenue Forecast, 2025–2031 (US$ Million) – by Indication
Table 73. Spain: Europe Hospital-at-Home Market – Revenue, 2021–2024 (US$ Million) – by End User
Table 74. Spain: Europe Hospital-at-Home Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User
Table 75. Netherlands: Europe Hospital-at-Home Market – Revenue, 2021–2024 (US$ Million) – by Component
Table 76. Netherlands: Europe Hospital-at-Home Market – Revenue Forecast, 2025–2031 (US$ Million) – by Component
Table 77. Netherlands: Europe Hospital-at-Home Market – Revenue, 2021–2024 (US$ Million) – by Service Type
Table 78. Netherlands: Europe Hospital-at-Home Market – Revenue Forecast, 2025–2031 (US$ Million) – by Service Type
Table 79. Netherlands: Europe Hospital-at-Home Market – Revenue, 2021–2024 (US$ Million) – by Delivery Mode
Table 80. Netherlands: Europe Hospital-at-Home Market – Revenue Forecast, 2025–2031 (US$ Million) – by Delivery Mode
Table 81. Netherlands: Europe Hospital-at-Home Market – Revenue, 2021–2024 (US$ Million) – by Patient Demographic
Table 82. Netherlands: Europe Hospital-at-Home Market – Revenue Forecast, 2025–2031 (US$ Million) – by Patient Demographic
Table 83. Netherlands: Europe Hospital-at-Home Market – Revenue, 2021–2024 (US$ Million) – by Indication
Table 84. Netherlands: Europe Hospital-at-Home Market – Revenue Forecast, 2025–2031 (US$ Million) – by Indication
Table 85. Netherlands: Europe Hospital-at-Home Market – Revenue, 2021–2024 (US$ Million) – by End User
Table 86. Netherlands: Europe Hospital-at-Home Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User
Table 87. Switzerland: Europe Hospital-at-Home Market – Revenue, 2021–2024 (US$ Million) – by Component
Table 88. Switzerland: Europe Hospital-at-Home Market – Revenue Forecast, 2025–2031 (US$ Million) – by Component
Table 89. Switzerland: Europe Hospital-at-Home Market – Revenue, 2021–2024 (US$ Million) – by Service Type
Table 90. Switzerland: Europe Hospital-at-Home Market – Revenue Forecast, 2025–2031 (US$ Million) – by Service Type
Table 91. Switzerland: Europe Hospital-at-Home Market – Revenue, 2021–2024 (US$ Million) – by Delivery Mode
Table 92. Switzerland: Europe Hospital-at-Home Market – Revenue Forecast, 2025–2031 (US$ Million) – by Delivery Mode
Table 93. Switzerland: Europe Hospital-at-Home Market – Revenue, 2021–2024 (US$ Million) – by Patient Demographic
Table 94. Switzerland: Europe Hospital-at-Home Market – Revenue Forecast, 2025–2031 (US$ Million) – by Patient Demographic
Table 95. Switzerland: Europe Hospital-at-Home Market – Revenue, 2021–2024 (US$ Million) – by Indication
Table 96. Switzerland: Europe Hospital-at-Home Market – Revenue Forecast, 2025–2031 (US$ Million) – by Indication
Table 97. Switzerland: Europe Hospital-at-Home Market – Revenue, 2021–2024 (US$ Million) – by End User
Table 98. Switzerland: Europe Hospital-at-Home Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User
Table 99. Belgium: Europe Hospital-at-Home Market – Revenue, 2021–2024 (US$ Million) – by Component
Table 100. Belgium: Europe Hospital-at-Home Market – Revenue Forecast, 2025–2031 (US$ Million) – by Component
Table 101. Belgium: Europe Hospital-at-Home Market – Revenue, 2021–2024 (US$ Million) – by Service Type
Table 102. Belgium: Europe Hospital-at-Home Market – Revenue Forecast, 2025–2031 (US$ Million) – by Service Type
Table 103. Belgium: Europe Hospital-at-Home Market – Revenue, 2021–2024 (US$ Million) – by Delivery Mode
Table 104. Belgium: Europe Hospital-at-Home Market – Revenue Forecast, 2025–2031 (US$ Million) – by Delivery Mode
Table 105. Belgium: Europe Hospital-at-Home Market – Revenue, 2021–2024 (US$ Million) – by Patient Demographic
Table 106. Belgium: Europe Hospital-at-Home Market – Revenue Forecast, 2025–2031 (US$ Million) – by Patient Demographic
Table 107. Belgium: Europe Hospital-at-Home Market – Revenue, 2021–2024 (US$ Million) – by Indication
Table 108. Belgium: Europe Hospital-at-Home Market – Revenue Forecast, 2025–2031 (US$ Million) – by Indication
Table 109. Belgium: Europe Hospital-at-Home Market – Revenue, 2021–2024 (US$ Million) – by End User
Table 110. Belgium: Europe Hospital-at-Home Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User
Table 111. Rest of Europe: Europe Hospital-at-Home Market – Revenue, 2021–2024 (US$ Million) – by Component
Table 112. Rest of Europe: Europe Hospital-at-Home Market – Revenue Forecast, 2025–2031 (US$ Million) – by Component
Table 113. Rest of Europe: Europe Hospital-at-Home Market – Revenue, 2021–2024 (US$ Million) – by Service Type
Table 114. Rest of Europe: Europe Hospital-at-Home Market – Revenue Forecast, 2025–2031 (US$ Million) – by Service Type
Table 115. Rest of Europe: Europe Hospital-at-Home Market – Revenue, 2021–2024 (US$ Million) – by Delivery Mode
Table 116. Rest of Europe: Europe Hospital-at-Home Market – Revenue Forecast, 2025–2031 (US$ Million) – by Delivery Mode
Table 117. Rest of Europe: Europe Hospital-at-Home Market – Revenue, 2021–2024 (US$ Million) – by Patient Demographic
Table 118. Rest of Europe: Europe Hospital-at-Home Market – Revenue Forecast, 2025–2031 (US$ Million) – by Patient Demographic
Table 119. Rest of Europe: Europe Hospital-at-Home Market – Revenue, 2021–2024 (US$ Million) – by Indication
Table 120. Rest of Europe: Europe Hospital-at-Home Market – Revenue Forecast, 2025–2031 (US$ Million) – by Indication
Table 121. Rest of Europe: Europe Hospital-at-Home Market – Revenue, 2021–2024 (US$ Million) – by End User
Table 122. Rest of Europe: Europe Hospital-at-Home Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User
Table 123. Glossary – Europe Hospital-at-Home Market
???????List of FiguresFigure 1. Europe Hospital-at-Home Market – Value Chain Analysis
Figure 2. Porter’s Five Forces Analysis
Figure 3. Pest Analysis
Figure 4. Europe Hospital-at-Home Market – Key Industry Dynamics
Figure 5. Impact Analysis of Drivers and Restraints
Figure 6. Europe Hospital-at-Home Market Revenue (US$ Million), 2021–2031
Figure 7. Europe Hospital-at-Home Market Share (%) – by Component (2024 and 2031)
Figure 8. Equipment and Devices: Europe Hospital-at-Home Market – Revenue and Forecasts, 2021–2031 (US$ Million)
Figure 9. Software and Services: Europe Hospital-at-Home Market – Revenue and Forecasts, 2021–2031 (US$ Million)
Figure 10. Europe Hospital-at-Home Market Share (%) – by Service Type (2024 and 2031)
Figure 11. Acute Care at Home: Europe Hospital-at-Home Market – Revenue and Forecasts, 2021–2031 (US$ Million)
Figure 12. Chronic Disease Management at Home: Europe Hospital-at-Home Market – Revenue and Forecasts, 2021–2031 (US$ Million)
Figure 13. Post Acute or Transitional Care: Europe Hospital-at-Home Market – Revenue and Forecasts, 2021–2031 (US$ Million)
Figure 14. Palliative Care and Hospice Care: Europe Hospital-at-Home Market – Revenue and Forecasts, 2021–2031 (US$ Million)
Figure 15. Rehabilitation Services: Europe Hospital-at-Home Market – Revenue and Forecasts, 2021–2031 (US$ Million)
Figure 16. Europe Hospital-at-Home Market Share (%) – by Delivery Mode (2024 and 2031)
Figure 17. Remote Monitoring and Telehealth: Europe Hospital-at-Home Market – Revenue and Forecasts, 2021–2031 (US$ Million)
Figure 18. In-person Home Visits: Europe Hospital-at-Home Market – Revenue and Forecasts, 2021–2031 (US$ Million)
Figure 19. Hybrid Models: Europe Hospital-at-Home Market – Revenue and Forecasts, 2021–2031 (US$ Million)
Figure 20. Europe Hospital-at-Home Market Share (%) – by Patient Demographic (2024 and 2031)
Figure 21. Adult Patients: Europe Hospital-at-Home Market – Revenue and Forecasts, 2021–2031 (US$ Million)
Figure 22. Pediatric Patients: Europe Hospital-at-Home Market – Revenue and Forecasts, 2021–2031 (US$ Million)
Figure 23. Europe Hospital-at-Home Market Share (%) – by Indication (2024 and 2031)
Figure 24. Cardiovascular Conditions: Europe Hospital-at-Home Market – Revenue and Forecasts, 2021–2031 (US$ Million)
Figure 25. Respiratory Diseases: Europe Hospital-at-Home Market – Revenue and Forecasts, 2021–2031 (US$ Million)
Figure 26. Orthopedic and Post-Surgical Recovery: Europe Hospital-at-Home Market – Revenue and Forecasts, 2021–2031 (US$ Million)
Figure 27. Infectious Diseases: Europe Hospital-at-Home Market – Revenue and Forecasts, 2021–2031 (US$ Million)
Figure 28. Neurological Rehabilitation: Europe Hospital-at-Home Market – Revenue and Forecasts, 2021–2031 (US$ Million)
Figure 29. Others: Europe Hospital-at-Home Market – Revenue and Forecasts, 2021–2031 (US$ Million)
Figure 30. Europe Hospital-at-Home Market Share (%) – by End User (2024 and 2031)
Figure 31. Hospitals and Health Systems: Europe Hospital-at-Home Market – Revenue and Forecasts, 2021–2031 (US$ Million)
Figure 32. Home Health Agencies: Europe Hospital-at-Home Market – Revenue and Forecasts, 2021–2031 (US$ Million)
Figure 33. Primary Care or Physician Groups: Europe Hospital-at-Home Market – Revenue and Forecasts, 2021–2031 (US$ Million)
Figure 34. Private HaH Providers: Europe Hospital-at-Home Market – Revenue and Forecasts, 2021–2031 (US$ Million)
Figure 35. Europe Hospital-at-Home Market Breakdown by Key Countries, 2024 and 2031 (%)
Figure 36. Germany: Europe Hospital-at-Home Market Revenue and Forecasts, 2021–2031 (US$ Million)
Figure 37. United Kingdom: Europe Hospital-at-Home Market Revenue and Forecasts, 2021–2031 (US$ Million)
Figure 38. France: Europe Hospital-at-Home Market Revenue and Forecasts, 2021–2031 (US$ Million)
Figure 39. Italy: Europe Hospital-at-Home Market Revenue and Forecasts, 2021–2031 (US$ Million)
Figure 40. Spain: Europe Hospital-at-Home Market Revenue and Forecasts, 2021–2031 (US$ Million)
Figure 41. Netherlands: Europe Hospital-at-Home Market Revenue and Forecasts, 2021–2031 (US$ Million)
Figure 42. Switzerland: Europe Hospital-at-Home Market Revenue and Forecasts, 2021–2031 (US$ Million)
Figure 43. Belgium: Europe Hospital-at-Home Market Revenue and Forecasts, 2021–2031 (US$ Million)
Figure 44. Rest of Europe: Europe Hospital-at-Home Market Revenue and Forecasts, 2021–2031 (US$ Million)
Figure 45. Bottom–Up Approach and Top–Down Approach
Yes! We provide a free sample of the report, which includes Report Scope (Table of Contents), report structure, and selected insights to help you assess the value of the full report. Please click on the "Download Sample" button or contact us to receive your copy.
Absolutely - analyst assistance is part of the package. You can connect with our analyst post-purchase to clarify report insights, methodology or discuss how the findings apply to your business needs.
Once your order is successfully placed, you will receive a confirmation email along with your invoice.
• For published reports: You'll receive access to the report within 4-6 working hours via a secured email sent to your email.
• For upcoming reports: Your order will be recorded as a pre-booking. Our team will share the estimated release date and keep you informed of any updates. As soon as the report is published, it will be delivered to your registered email.
We offer customization options to align the report with your specific objectives. Whether you need deeper insights into a particular region, industry segment, competitor analysis, or data cut, our research team can tailor the report accordingly. Please share your requirements with us, and we'll be happy to provide a customized proposal or scope.
The report is available in either PDF format or as an Excel dataset, depending on the license you choose.
The PDF version provides the full analysis and visuals in a ready-to-read format. The Excel dataset includes all underlying data tables for easy manipulation and further analysis.
Please review the license options at checkout or contact us to confirm which formats are included with your purchase.
Our payment process is fully secure and PCI-DSS compliant.
We use trusted and encrypted payment gateways to ensure that all transactions are protected with industry-standard SSL encryption. Your payment details are never stored on our servers and are handled securely by certified third-party processors.
You can make your purchase with confidence, knowing your personal and financial information is safe with us.
Yes, we do offer special pricing for bulk purchases.
If you're interested in purchasing multiple reports, we're happy to provide a customized bundle offer or volume-based discount tailored to your needs. Please contact our sales team with the list of reports you're considering, and we'll share a personalized quote.
Yes, absolutely.
Our team is available to help you make an informed decision. Whether you have questions about the report's scope, methodology, customization options, or which license suits you best, we're here to assist. Please reach out to us at sales@theinsightpartners.com, and one of our representatives will get in touch promptly.
Yes, a billing invoice will be automatically generated and sent to your registered email upon successful completion of your purchase.
If you need the invoice in a specific format or require additional details (such as company name, GST, or VAT information), feel free to contact us, and we'll be happy to assist.
Yes, certainly.
If you encounter any difficulties accessing or receiving your report, our support team is ready to assist you. Simply reach out to us via email or live chat with your order information, and we'll ensure the issue is resolved quickly so you can access your report without interruption.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For